MicroRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: Progress and challenges

Molecular BioSystems

Volumn 11, Issue 5, 2015, Pages 1217-1234

  Seyhan, Attila A ^a,b  

^a FLORIDA HOSPITAL   (United States)

^b Massachusetts Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ANIMAL; DIABETES MELLITUS; DISEASE COURSE; DRUG RESISTANCE; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; METABOLISM; PHARMACOGENETICS; PROGNOSIS;

ANIMALS; BIOMARKERS; DIABETES MELLITUS; DISEASE PROGRESSION; DRUG RESISTANCE; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; PHARMACOGENETICS; PROGNOSIS;

EID: 84928138263     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c5mb00064e     Document Type: Review

References (173)

1. A. A. Seyhan Biomarkers in drug discovery and development Eur. Biopharm. Rev. 2010 19 25
2. G. Poste Bring on the biomarkers Nature 2011 469 156 157
3. B. John et al., Human MicroRNA targets PLoS Biol. 2004 2 e363
4. R. S. Pillai MicroRNA function: multiple mechanisms for a tiny RNA? RNA 2005 11 1753 1761
5. L. P. Lim et al., The microRNAs of Caenorhabditis elegans Genes Dev. 2003 17 991 1008
6. miRBase. Homo sapiens miRNAs in the miRBase at Manchester University
7. I. Bentwich et al., Identification of hundreds of conserved and nonconserved human microRNAs Nat. Genet. 2005 37 766 770
8. R. C. Friedman K. K. Farh C. B. Burge D. P. Bartel Most mammalian mRNAs are conserved targets of microRNAs Genome Res. 2009 19 92 105
9. B. P. Lewis C. B. Burge D. P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 2005 120 15 20
10. A. T. Willingham T. R. Gingeras TUF love for "junk" DNA Cell 2006 125 1215 1220
11. E. E. Creemers A. J. Tijsen Y. M. Pinto Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ. Res. 2012 110 483 495
12. A. Osman MicroRNAs in health and disease-basic science and clinical applications Clin. Lab. 2012 58 393 402
13. I. Alevizos G. G. Illei MicroRNAs as biomarkers in rheumatic diseases Nat. Rev. Rheumatol. 2010 6 391 398
14. A. Etheridge I. Lee L. Hood D. Galas K. Wang Extracellular microRNA: a new source of biomarkers Mutat. Res. 2011 717 85 90
15. G. Reid M. B. Kirschner N. van Zandwijk Circulating microRNAs: Association with disease and potential use as biomarkers Crit. Rev. Oncol. Hematol. 2011 80 193 208
16. Y. Chen J. A. Gelfond L. M. McManus P. K. Shireman Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis BMC Genomics 2009 10 407
17. J. Ai et al., Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction Biochem. Biophys. Res. Commun. 2010 391 73 77
18. W. C. Cho Great potential of miRNAs as predictive and prognostic markers for cancer Expert Rev. Mol. Diagn. 2012 12 315 318
19. M. G. Schrauder et al., Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection PLoS One 2012 7 e29770
20. A. R. Ranade et al., MicroRNA 92a-2∗: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer J. Thorac. Oncol. 2010 5 1273 1278
21. C. Roth et al., Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer Breast Cancer Res. 2010 12 R90
22. A. M. Liu et al., Global regulation on microRNA in hepatitis B virus-associated hepatocellular carcinoma OMICS 2011 15 187 191
23. C. H. Lawrie et al., Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma Br. J. Haematol. 2008 141 672 675
24. W. Zhang M. E. Dolan The emerging role of microRNAs in drug responses Curr. Opin. Mol. Ther. 2010 12 695 702
25. M. Montano MicroRNAs: miRRORS of health and disease Transl. Res. 2011 157 157 162
26. G. W. Dorn, 2nd MicroRNAs in cardiac disease Transl. Res. 2011 157 226 235
27. M. F. Corsten et al., Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease Circ.: Cardiovasc. Genet. 2010 3 499 506
28. Y. Devaux et al., Use of circulating microRNAs to diagnose acute myocardial infarction Clin. Chem. 2012 58 559 567
29. Y. Cheng et al., A translational study of circulating cell-free microRNA-1 in acute myocardial infarction Clin. Sci. 2010 119 87 95
30. X. Ji et al., Plasma miR-208 as a biomarker of myocardial injury Clin. Chem. 2009 55 1944 1949
31. C. Guay E. Roggli V. Nesca C. Jacovetti R. Regazzi Diabetes mellitus, a microRNA-related disease? Transl. Res. 2011 157 253 264
32. A. Zampetaki et al., Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes Circ. Res. 2010 107 810 817
33. A. Granjon et al., The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway Diabetes 2009 58 2555 2564
34. C. E. Burd et al., Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk PLoS Genet. 2010 6 e1001233
35. C. Vasilescu et al., MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis PLoS One 2009 4 e7405
36. K. V. Pandit J. Milosevic N. Kaminski MicroRNAs in idiopathic pulmonary fibrosis Transl. Res. 2011 157 191 199
37. T. Zhou J. G. Garcia W. Zhang Integrating microRNAs into a system biology approach to acute lung injury Transl. Res. 2011 157 180 190
38. J. Feng et al., Evidence for X-chromosomal schizophrenia associated with microRNA alterations PLoS One 2009 4 e6121
39. B. H. Miller et al., MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function Proc. Natl. Acad. Sci. U. S. A. 2012 109 3125 3130
40. G. Sorensen et al., Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes BMC Genomics 2008 9 114
41. J. Montag et al., Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease Mol. Neurodegener. 2009 4 36
42. R. Saba C. D. Goodman R. L. Huzarewich C. Robertson S. A. Booth A miRNA signature of prion induced neurodegeneration PLoS One 2008 3 e3652
43. A. Gomez M. Ingelman-Sundberg Epigenetic and microRNA-dependent control of cytochrome P450 expression: a gap between DNA and protein Pharmacogenomics 2009 10 1067 1076
44. K. K. To et al., Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2 Mol. Cancer Ther. 2009 8 2959 2968
45. P. Krishnamurthy J. D. Schuetz Role of ABCG2/BCRP in biology and medicine Annu. Rev. Pharmacol. Toxicol. 2006 46 381 410
46. Y. Lu et al., MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection Cardiovasc. Res. 2009 84 434 441
47. H. Chen N. Wang M. Burmeister M. G. McInnis MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment Int. J. Neuropsychopharmacol. 2009 12 975 981
48. R. Hummel D. J. Hussey J. Haier MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types Eur. J. Cancer 2010 46 298 311
49. T. Kushibiki Photodynamic therapy induces microRNA-210 and -296 expression in HeLa cells J. Biophotonics 2010 3 368 372
50. J. Buckland Biomarkers: microRNAs under the spotlight in inflammatory arthritis Nat. Rev. Rheumatol. 2010 6 436
51. S. K. Ajit Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules Sensors 2012 12 3359 3369
52. A. E. Szafranska-Schwarzbach, et al., A Multi-center Study of a MicroRNA-based Assay for the Diagnosis of Pancreatic Ductal Adenocarcinoma in Fine Needle Aspirates, The American Pancreatic Association (APA) Annual Meeting, November 2-5, 2011 in Chicago, 2011
53. R. J. Farr M. V. Joglekar C. J. Taylor A. A. Hardikar Circulating non-coding RNAs as biomarkers of beta cell death in diabetes Pediatr. Endocrinol. Rev. 2013 11 14 20
54. P. S. Mitchell et al., Circulating microRNAs as stable blood-based markers for cancer detection Proc. Natl. Acad. Sci. U. S. A. 2008 105 10513 10518
55. W. Zhu W. Qin U. Atasoy E. R. Sauter Circulating microRNAs in breast cancer and healthy subjects BMC Res. Notes 2009 2 89
56. P. K. Lim et al., Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells Cancer Res. 2011 71 1550 1560
57. Y. Zhang et al., Secreted monocytic miR-150 enhances targeted endothelial cell migration Mol. Cell 2010 39 133 144
58. N. Kosaka et al., Secretory mechanisms and intercellular transfer of microRNAs in living cells J. Biol. Chem. 2010 285 17442 17452
59. M. Yang et al., Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells Mol. Cancer 2011 10 117
60. E. Anastasiadou F. J. Slack Cancer. Malicious exosomes Science 2014 346 1459 1460
61. C. Roma-Rodrigues A. R. Fernandes P. V. Baptista Exosome in tumour microenvironment: overview of the crosstalk between normal and cancer cells BioMed Res. Int. 2014 2014 179486
62. H. Valadi et al., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat. Cell Biol. 2007 9 654 659
63. O. Rechavi et al., Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs Genes Dev. 2009 23 1971 1979
64. J. Skog et al., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers Nat. Cell Biol. 2008 10 1470 1476
65. A. Zernecke et al., Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection Sci. Signaling 2009 2 ra81
66. S. A. Melo et al., Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis Cancer Cell 2014 26 707 721
67. M. Fabbri et al., MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response Proc. Natl. Acad. Sci. U. S. A. 2012 109 E2110 E2116
68. X. Chen H. Liang J. Zhang K. Zen C. Y. Zhang Secreted microRNAs: a new form of intercellular communication Trends Cell Biol. 2012 22 125 132
69. F. Collino et al., Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs PLoS One 2010 5 e11803
70. A. Yuan et al., Transfer of microRNAs by embryonic stem cell microvesicles PLoS One 2009 4 e4722
71. K. C. Vickers B. T. Palmisano B. M. Shoucri R. D. Shamburek A. T. Remaley MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins Nat. Cell Biol. 2011 13 423 433
72. H. Iguchi N. Kosaka T. Ochiya Secretory microRNAs as a versatile communication tool Commun. Integr. Biol. 2010 3 478 481
73. I. J. Gallagher et al., Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes Genome Med. 2010 2 9
74. L. Pigati et al., Selective release of microRNA species from normal and malignant mammary epithelial cells PLoS One 2010 5 e13515
75. S. Erener M. Mojibian J. K. Fox H. C. Denroche T. J. Kieffer Circulating miR-375 as a biomarker of beta-cell death and diabetes in mice Endocrinology 2013 154 603 608
76. A. El Ouaamari et al., miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells Diabetes 2008 57 2708 2717
77. M. N. Poy et al., miR-375 maintains normal pancreatic alpha- and beta-cell mass Proc. Natl. Acad. Sci. U. S. A. 2009 106 5813 5818
78. H. Zhao et al., Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition Pancreas 2010 39 843 846
79. V. Bravo-Egana et al., Quantitative differential expression analysis reveals miR-7 as major islet microRNA Biochem. Biophys. Res. Commun. 2008 366 922 926
80. D. S. Karolina et al., Circulating miRNA profiles in patients with metabolic syndrome J. Clin. Endocrinol. Metab. 2012 97 E2271 E2276
81. H. Xie B. Lim H. F. Lodish MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity Diabetes 2009 58 1050 1057
82. N. Kloting et al., MicroRNA expression in human omental and subcutaneous adipose tissue PLoS One 2009 4 e4699
83. H. M. Heneghan N. Miller O. J. McAnena T. O'Brien M. J. Kerin Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers J. Clin. Endocrinol. Metab. 2011 96 E846 E850
84. F. J. Ortega et al., MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation PLoS One 2010 5 e9022
85. P. Muhonen H. Holthofer Epigenetic and microRNA-mediated regulation in diabetes Nephrol., Dial., Transplant. 2009 24 1088 1096
86. H. M. Heneghan N. Miller M. J. Kerin Role of microRNAs in obesity and the metabolic syndrome Obes. Rev. 2010 11 354 361
87. M. Trajkovski et al., MicroRNAs 103 and 107 regulate insulin sensitivity Nature 2011 474 649 653
88. M. W. Schwartz D. Porte, Jr. Diabetes, obesity, and the brain Science 2005 307 375 379
89. R. Ogawa et al., Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation Biochem. Biophys. Res. Commun. 2010 398 723 729
90. M. Hulsmans D. De Keyzer P. Holvoet MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis FASEB J. 2011 25 2515 2527
91. G. Muller Microvesicles/exosomes as potential novel biomarkers of metabolic diseases Diabetes, Metab. Syndr. Obes.: Targets Ther. 2012 247 282
92. A. Zampetaki M. Mayr MicroRNAs in vascular and metabolic disease Circ. Res. 2012 110 508 522
93. J. Krutzfeldt et al., Silencing of microRNAs in vivo with 'antagomirs' Nature 2005 438 685 689
94. C. Guay R. Regazzi Circulating microRNAs as novel biomarkers for diabetes mellitus Nat. Rev. Endocrinol. 2013 9 513 521
95. J. A. Kolberg et al., Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort Diabetes Care 2009 32 1207 1212
96. V. Plaisance et al., MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells J. Biol. Chem. 2006 281 26932 26942
97. J. A. Wagner S. A. Williams C. J. Webster Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs Clin. Pharmacol. Ther. 2007 81 104 107
98. J. E. Fish et al., miR-126 regulates angiogenic signaling and vascular integrity Dev. Cell 2008 15 272 284
99. L. Kong et al., Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study Acta Diabetol. 2011 48 61 69
100. F. J. Ortega et al., Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization Diabetes Care 2014 37 1375 1383
101. K. A. Cissell S. K. Deo Trends in microRNA detection Anal. Bioanal. Chem. 2009 394 1109 1116
102. C. C. Pritchard H. H. Cheng M. Tewari MicroRNA profiling: approaches and considerations Nat. Rev. Genet. 2012 13 358 369
103. J. Shingara et al., An optimized isolation and labeling platform for accurate microRNA expression profiling RNA 2005 11 1461 1470
104. C. Chen et al., Real-time quantification of microRNAs by stem-loop RT-PCR Nucleic Acids Res. 2005 33 e179
105. K. Kang X. Peng J. Luo D. Gou Identification of circulating miRNA biomarkers based on global quantitative real-time PCR profiling J. Anim. Sci. Biotechnol. 2012 3 4
106. H. P. Buermans Y. Ariyurek G. van Ommen J. T. den Dunnen P. A. t Hoen New methods for next generation sequencing based microRNA expression profiling BMC Genomics 2010 11 716
107. R. E. Lanford et al., Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 2010 327 198 201
108. A. Keller et al., Toward the blood-borne miRNome of human diseases Nat. Methods 2011 8 841 843
109. P. T. Nelson W. X. Wang B. R. Wilfred G. Tang Technical variables in high-throughput miRNA expression profiling: much work remains to be done Biochim. Biophys. Acta 2008 1779 758 765
110. L. W. Lee et al., Complexity of the microRNA repertoire revealed by next-generation sequencing RNA 2010 16 2170 2180
111. M. F. Thomas K. M. Ansel Construction of small RNA cDNA libraries for deep sequencing Methods Mol. Biol. 2010 667 93 111
112. A. Aravin T. Tuschl Identification and characterization of small RNAs involved in RNA silencing FEBS Lett. 2005 579 5830 5840
113. M. Hafner et al., RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries RNA 2011 17 1697 1712
114. S. E. Linsen et al., Limitations and possibilities of small RNA digital gene expression profiling Nat. Methods 2009 6 474 476
115. G. Tian et al., Sequencing bias: comparison of different protocols of microRNA library construction BMC Biotechnol. 2010 10 64
116. H. A. Ebhardt et al., Meta-analysis of small RNA-sequencing errors reveals ubiquitous post-transcriptional RNA modifications Nucleic Acids Res. 2009 37 2461 2470
117. S. L. Fernandez-Valverde R. J. Taft J. S. Mattick Dynamic isomiR regulation in Drosophila development RNA 2010 16 1881 1888
118. H. M. Heneghan N. Miller M. J. Kerin Circulating microRNAs: promising breast cancer Biomarkers Breast Cancer Res. 2011 13 402; author reply 403
119. F. Sato S. Tsuchiya K. Terasawa G. Tsujimoto Intra-platform repeatability and inter-platform comparability of microRNA microarray technology PLoS One 2009 4 e5540
120. A. Zampetaki P. Willeit I. Drozdov S. Kiechl M. Mayr Profiling of circulating microRNAs: from single biomarkers to re-wired networks Cardiovasc. Res. 2012 93 555 562
121. R. Duttagupta R. Jiang J. Gollub R. C. Getts K. W. Jones Impact of cellular miRNAs on circulating miRNA biomarker signatures PLoS One 2011 6 e20769
122. C. H. Chau O. Rixe H. McLeod W. D. Figg Validation of analytic methods for biomarkers used in drug development Clin. Cancer Res. 2008 14 5967 5976
123. K. J. Miller et al., Workshop on bioanalytical methods validation for macromolecules: summary report Pharm. Res. 2001 18 1373 1383
124. J. W. Findlay et al., Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective J. Pharm. Biomed. Anal. 2000 21 1249 1273
125. J. W. Lee J. D. Hulse W. A. Colburn Surrogate biochemical markers: precise measurement for strategic drug and biologics development J. Clin. Pharmacol. 1995 35 464 470
126. R. Dybkaer Vocabulary for use in measurement procedures and description of reference materials in laboratory medicine Eur. J. Clin. Chem. Clin. Biochem. 1997 35 141 173
127. S. Fichtlscherer et al., Circulating microRNAs in patients with coronary artery disease Circ. Res. 2010 107 677 684
128. S. K. Gupta C. Bang T. Thum Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease Circ.: Cardiovasc. Genet. 2010 3 484 488
129. C. Widera et al., Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome J. Mol. Cell. Cardiol. 2011 51 872 875
130. J. Shaffer M. Schlumpberger E. Lader miRNA profiling from blood-challenges and recommendations Qiagen Scientific article 2012 1 10
131. J. A. Wagner Overview of biomarkers and surrogate endpoints in drug development Dis. Markers 2002 18 41 46
132. C. Carini and A. A. Seyhan, Biomarkers for Drug Development: The Time is Now, in Clincial and Statistical Considerations in Personalized Medicine, ed., C. Carini, S. Menon, and, M. Cheng, 2014, pp. 1-26
133. J. Gui et al., Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies Clin. Sci. 2011 120 183 193
134. A. J. Williams A. E. Long Following the Fate of the Failing beta-Cell: New Insights From First-Phase Insulin Responses Diabetes 2013 62 3990 3992
135. K. J. Rayner et al., Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides Nature 2011 478 404 407
136. K. J. Rayner et al., MiR-33 contributes to the regulation of cholesterol homeostasis Science 2010 328 1570 1573
137. T. J. Marquart R. M. Allen D. S. Ory A. Baldan miR-33 links SREBP-2 induction to repression of sterol transporters Proc. Natl. Acad. Sci. U. S. A. 2010 107 12228 12232
138. D. Iliopoulos K. Drosatos Y. Hiyama I. J. Goldberg V. I. Zannis MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism J. Lipid Res. 2010 51 1513 1523
139. J. D. Wulfkuhle C. P. Paweletz P. S. Steeg E. F. Petricoin 3rd L. Liotta Proteomic approaches to the diagnosis, treatment, and monitoring of cancer Adv. Exp. Med. Biol. 2003 532 59 68
140. Q. Wang et al., miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130 Proc. Natl. Acad. Sci. U. S. A. 2008 105 2889 2894
141. Y. Ye Z. Hu Y. Lin C. Zhang J. R. Perez-Polo Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury Cardiovasc. Res. 2010 87 535 544
142. B. R. Wilfred W. X. Wang P. T. Nelson Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways Mol. Genet. Metab. 2007 91 209 217
143. C. Esau et al., MicroRNA-143 regulates adipocyte differentiation J. Biol. Chem. 2004 279 52361 52365
144. M. N. Poy et al., A pancreatic islet-specific microRNA regulates insulin secretion Nature 2004 432 226 230
145. S. L. Fernandez-Valverde R. J. Taft J. S. Mattick MicroRNAs in beta-cell biology, insulin resistance, diabetes and its complications Diabetes 2011 60 1825 1831
146. P. Lovis S. Gattesco R. Regazzi Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs Biol. Chem. 2008 389 305 312
147. H. Zhu et al., The Lin28/let-7 axis regulates glucose metabolism Cell 2011 147 81 94
148. T. Chen et al., MicroRNA-146a regulates the maturation process and pro-inflammatory cytokine secretion by targeting CD40L in oxLDL-stimulated dendritic cells FEBS Lett. 2011 585 567 573
149. G. Curtale et al., An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes Blood 2010 115 265 273
150. L. F. Lu et al., Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses Cell 2010 142 914 929
151. S. D. Hsu et al., miRTarBase: a database curates experimentally validated microRNA-target interactions Nucleic Acids Res. 2011 39 D163 D169
152. T. Melkman-Zehavi et al., miRNAs control insulin content in pancreatic beta-cells via downregulation of transcriptional repressors EMBO J. 2011 30 835 845
153. G. G. Illei E. Tackey L. Lapteva P. E. Lipsky Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability Arthritis Rheum. 2004 50 1709 1720
154. B. N. Davis A. C. Hilyard G. Lagna A. Hata SMAD proteins control DROSHA-mediated microRNA maturation Nature 2008 454 56 61
155. C. Sabatel et al., MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells PLoS One 2011 6 e16979
156. B. N. Davis A. C. Hilyard P. H. Nguyen G. Lagna A. Hata Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype J. Biol. Chem. 2009 284 3728 3738
157. X. Liu et al., A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia Circ. Res. 2009 104 476 487
158. P. Dentelli et al., microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression Arterioscler., Thromb., Vasc. Biol. 2010 30 1562 1568
159. L. Poliseno et al., MicroRNAs modulate the angiogenic properties of HUVECs Blood 2006 108 3068 3071
160. Y. Cheng et al., Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4 Cardiovasc. Res. 2010 87 431 439
161. K. R. Cordes et al., miR-145 and miR-143 regulate smooth muscle cell fate and plasticity Nature 2009 460 705 710
162. M. Quintavalle L. Elia G. Condorelli S. A. Courtneidge MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro J. Cell Biol. 2010 189 13 22
163. M. Xin et al., MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury Genes Dev. 2009 23 2166 2178
164. M. Parrizas et al., Circulating miR-192 and miR-193b are markers of prediabetes and are modulated by an exercise intervention J. Clin. Endocrinol. Metab. 2014 jc20142574
165. L. Sun et al., Mir193b-365 is essential for brown fat differentiation Nat. Cell Biol. 2011 13 958 965
166. S. G. Tattikota et al., Argonaute2 mediates compensatory expansion of the pancreatic beta cell Cell Metab. 2014 19 122 134
167. N. Rifai R. E. Gerszten Biomarker discovery and validation Clin. Chem. 2006 52 1635 1637
168. M. V. Joglekar V. M. Joglekar A. A. Hardikar Expression of islet-specific microRNAs during human pancreatic development Gene Expression Patterns 2009 9 109 113
169. G. Sebastiani et al., MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications J. Biomed. Sci. Eng. 2013 6 58 64
170. L. B. Nielsen et al., Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression Exp. Diabetes Res. 2012 2012 896362
171. G. Sebastiani et al., MicroRNA expression fingerprint in serum of type 1 diabetic patients Diabetologia 2012 55 S48
172. F. Salas-Perez et al., MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes Immunobiology 2013 218 733 737
173. G. Sebastiani et al., Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity Diabetes/Metab. Res. Rev. 2011 27 862 866